Reviews focused topics โ both clinical and basic science - in the fast-moving area of IBD, providing emphasis on the current challenges faced in the successful management of the disease
Turn to Challenges in Inflammatory Bowel Disease (IBD) when you need an expert opinion on the new, unusual or controversial areas of IBD and not just the tried and tested information. Current and concise reviews of the latest scientific discoveries are translated into cutting-edge clinical guidance to address those challenging cases faced by every medical team caring for patients with IBD.
Refer to this book to answer burning questions, to read an in depth review of the controversial topics and to provide a clear explanation of issues.Content:
Chapter 1 Global Changes in Incidence (pages 1โ13): Richard F. A. Logan and Emma L. Armitage
Chapter 2 The Role of Genetics in Inflammatory Bowel Disease (pages 14โ32): John B. Beckly, Tariq Ahmad and Derek P. Jewell
Chapter 3 Microbial Sensing in the Intestine by Pattern Recognition Receptors (pages 33โ43): Robin G. Lorenz and Charles O. Elson
Chapter 4 The Role of Bacteria (pages 44โ56): Robert Penner and Karen Madsen
Chapter 5 The Appendix ? How Might it Influence Susceptibility to Ulcerative Colitis: The Legend of Qebehsenuef (pages 57โ63): Kenneth Croitoru
Chapter 6 What are the Controversies in Histopathological Diagnosis? (pages 65โ84): Bryan F. Warren and Neil A. Shepherd
Chapter 7 The Challenges of using Capsule Endoscopy in the Diagnosis and Management of Inflammatory Bowel Disease (pages 85โ104): Gary C. Chen and Simon K. Lo
Chapter 8 Cross?Sectional Imaging of Inflammatory Bowel Disease (pages 105โ116): Stuart Taylor and Steve Halligan
Chapter 9 Mesalazine for Maintenance Therapy in Ulcerative Colitis ? How much, How long? (pages 117โ123): Miles P. Sparrow, Wee?Chian Lim and Stephen B. Hanauer
Chapter 10 Refractory Distal Colitis (pages 124โ143): Simon Travis
Chapter 11 Pharmabiotics and Inflammatory Bowel Disease ? On the Verge of Evidence?based Medicine (pages 144โ153): Fergus Shanahan, Jude Ryan and Shomik Sibartie
Chapter 12 Current Controversies in the Surgical Management of Ulcerative Colitis (pages 154โ166): R. John Nicholls and Mark J. Cheetham
Chapter 13 What are the Causes and Treatment of Ileoanal Pouch Dysfunction? (pages 167โ178): Alan F. Horgan, William J. Sandborn and John H. Pemberton
Chapter 14 Is Mesalazine Useful in Crohn's Disease? (pages 179โ193): A. Hillary Steinhart
Chapter 15 Steroids or Nutrition? (pages 194โ205): Miquel A. Gassull
Chapter 16 Do Antibiotics have a Role in Crohn's Disease? (pages 206โ212): Severine Vermeire and Paul Rutgeerts
Chapter 17 The Optimal use of Infliximab in Crohn's Disease (pages 213โ220): Geert D'Haens
Chapter 18 Designer Drugs: From Bench to Bedside (pages 221โ231): Stephan R. Targan and Loren C. Karp
Chapter 19 Current Controversies in the Surgical Management of Crohn's Disease (pages 232โ245): W. M. Chambers, I. Lindsey and N. J. Mortensen
Chapter 20 Perianal Crohn's Disease (pages 246โ265): Carl J. Brown and Robin S. McLeod
Chapter 21 What is Dysplasia? (pages 266โ280): Karel Geboes
Chapter 22 Colonoscopic Surveillance โ If and When? (pages 281โ292): Urban Sjoqvist and Robert Lofberg
Chapter 23 Cancer: New Colonoscopic Techniques (pages 293โ302): Ralf Kiesslich and Markus F. Neurath
Chapter 24 Molecular Markers ? A Realistic Hope? (pages 303โ311): Jacintha N. O'Sullivan and Teresa A. Brentnall
Chapter 25 Adenomas versus Dysplasia Associated Lesion or Mass ? Recognition and Management? (pages 312โ326): Maha Guindi and Robert H. Riddell
Chapter 26 Growth Impairment in Children (pages 327โ339): Thomas D. Walters and Anne M. Griffiths
Chapter 27 Osteopenia (pages 340โ359): Subrata Ghosh
Chapter 28 Pregnancy (pages 360โ368): Philippe Marteau
Chapter 29 Can Prognosis of Ulcerative Colitis be Predicted? (pages 369โ376): Robert Hilsden and Lloyd Sutherland